Primary Effusion Lymphoma
Information
- Disease name
- Primary Effusion Lymphoma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03038672 | Active, not recruiting | Phase 2 | Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas | December 21, 2018 | October 25, 2024 |
| NCT04742387 | Active, not recruiting | Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis | February 4, 2021 | December 31, 2024 | |
| NCT02911142 | Active, not recruiting | Phase 1/Phase 2 | Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma | July 3, 2017 | October 1, 2027 |
| NCT01193842 | Completed | Phase 1/Phase 2 | Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas | October 6, 2010 | May 19, 2022 |
| NCT02652715 | Completed | N/A | Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma | January 19, 2016 | November 12, 2019 |
| NCT05544019 | Recruiting | Phase 1 | Study of SGR-1505 in Mature B-Cell Neoplasms | April 10, 2023 | March 2026 |
| NCT00006518 | Recruiting | Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer | December 6, 2000 | ||
| NCT02228512 | Withdrawn | Phase 1/Phase 2 | Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas | August 15, 2014 | May 5, 2015 |
- OrphaNumber from OrphaNet (Orphanet)
- 48686